Antibody induced CD4 down-modulation of T cells is site-specifically mediated by CD64+ cells
Treatment of PBMC with the CD4-specific mAb BT-061 induces CD4 down-modulation of T cells. Here we report that addition of BT-061 to purified T cells did not confer this effect, whereas incubation of T cells in BT-061 coated wells restored CD4 down-modulation. These results implied that Fcγ receptor...
Main Authors: | Vogel, Stephanie, Grabski, Elena, Buschjäger, Daniela, Klawonn, Frank, Döring, Marius, Wang, Junxi, Fletcher, Erika, Bechmann, Ingo, Witte, Torsten, Durisin, Martin, Schraven, Burkhart, Mangsbo, Sara M., Schönfeld, Kurt, Czeloth, Niklas, Kalinke, Ulrich |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4680940/ |
Similar Items
-
Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies
by: Waibler, Zoe, et al.
Published: (2008) -
Monocytic and neutrophilic CD11b and CD64 in severe sepsis
by: Jämsä, J, et al.
Published: (2012) -
CD64 as a potential biomarker in septic arthritis
by: Oppegaard, Oddvar, et al.
Published: (2013) -
Diagnosis of infection utilizing accellix CD64
by: Sprung, CL, et al.
Published: (2015) -
Early changes in the metabolic profile of activated CD8+ T cells
by: Cammann, Clemens, et al.
Published: (2016)